Management of the Patient With HIV/Hepatitis C Drug Interactions: A Guide for Nurses and Nurse Practitioners

Laura E. Starbird, Hyejeong Hong, Mark S. Sulkowski, Jason E. Farley

Research output: Contribution to journalArticlepeer-review

Abstract

Approximately one third of patients coinfected with HIV and hepatitis C virus (HCV) who initiate direct-acting antivirals (DAAs) for HCV treatment may have to switch antiretroviral therapy (ART) because of drug interactions. ART switches can negatively affect quality of life, increase HIV symptom burden, and delay HCV therapy. Approaches to identify ART/DAA drug interactions that minimize the impact of switching ART are urgently needed. Nurses can lead the way in addressing this new and major need. We provide a guide for registered nurses and nurse practitioners who care for patients coinfected with HIV and HCV to identify HIV/HCV drug interactions and manage ART/DAA coadministration when needed.

Original languageEnglish (US)
Pages (from-to)241-248
Number of pages8
JournalThe Journal of the Association of Nurses in AIDS Care : JANAC
Volume31
Issue number2
DOIs
StatePublished - Mar 1 2020

ASJC Scopus subject areas

  • Advanced and Specialized Nursing

Fingerprint Dive into the research topics of 'Management of the Patient With HIV/Hepatitis C Drug Interactions: A Guide for Nurses and Nurse Practitioners'. Together they form a unique fingerprint.

Cite this